Replicor

Replicor is a clinical-stage company developing novel NUCLEIC ACID-BASED POLYMERS (NAPs): oligonucleotides whose antiviral activity is strictly dependent on the polymer chemistry of oligonucleotides which can be preserved independently of the sequence of nucleotides present. NAPs have a very important safety advantage over all other existing oligonucleotide-based drugs such as aptamers, antisense oligonucleotides and siRNA: because NAP’s activity is not sequence dependent, NAPs can be engineered with sequences which retain antiviral activity but which do not have pro-inflammatory activity or off target effects common with other oligonucleotide-based drugs, rendering them safe and well tolerated.
Company Growth (employees)
Type
Private
HQ
Montreal, CA
Size (employees)
7 (est)
Replicor is headquartered in Montreal, CA

Replicor Office Locations

Replicor has an office in Montreal
Montreal, CA (HQ)
6100 Royalmount Ave

Replicor Financials and Metrics

Summary Metrics

Investors

Replicor's Web-traffic and Trends

Replicor Online and Social Media Presence

Replicor Company Life and Culture

You may also be interested in